No Data
No Data
Is Certara (NASDAQ:CERT) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2024
Certara Is Maintained at Equal-Weight by Barclays
Certara Is Maintained at Equal-Weight by Barclays
Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating
Certara (CERT) has an average outperform rating and a price target range of $15.50 to $23, according to analysts polled by Capital IQ. Price: 13.41, Change: -0.24, Percent Change: -1.76
Certara Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 19.41% Barclays $18 → $16 Maintains Equal-Weight 04/10/2024 71.65% Keybanc → $23 Upgrades Secto
Express News | Certara : Barclays Cuts Target Price to $16 From $18